Tropical Disease
4
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by Ivermectin Diethylcarbamazine Albendazole
Research Leaders
5 sponsors active, led by National Public Health Institute of Liberia
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
Collection of Human Biological Samples for the Development and Validation of New Methods of Diagnosis and for the Realization of Expertises Diagnostics in the Field of Infectious Diseases and Tropical
Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study
A Pilot Study Examining for the Presence of Fecal Coliforms and Tropical Diseases in Peru
Research Network
Common Treatments
- Ivermectin Diethylcarbamazine Albendazole1
- Dengue1
- Biological Samples1
- Chikagunya1
- Zika1
Active Sponsors
- National Public Health Institute of Liberia1
- Washington University School of Medicine1
- All India Institute of Medical Sciences1
- BioRed LLC1
- Institut Pasteur1
Top Investigators
National Public Health Institute of Liberia
All India Institute of Medical Sciences
All India Institute of Medical Sciences
Washington University School of Medicine
Washington University School of Medicine
Related Conditions
- Tenia Solium Infection1
- Infectious Disease1
- Onchocercal Subcutaneous Nodule1
- Onchocerca Infection1
- Neurocysticercosis1